Suppr超能文献

成人细支气管炎。一种与气道中性粒细胞及中性粒细胞产物相关的气道阻塞可逆性病因。

Bronchiolitis in adults. A reversible cause of airway obstruction associated with airway neutrophils and neutrophil products.

作者信息

Kindt G C, Weiland J E, Davis W B, Gadek J E, Dorinsky P M

机构信息

Department of Medicine, Ohio State University, Columbus 43210.

出版信息

Am Rev Respir Dis. 1989 Aug;140(2):483-92. doi: 10.1164/ajrccm/140.2.483.

Abstract

In the past 4 yr, 16 adult patients were identified who had accelerated onset of a severe respiratory disorder (usually obstructive in nature) that was clinically distinct from the more commonly encountered chronic obstructive disorders (e.g., chronic bronchitis, emphysema, asthma, bronchiectasis, cystic fibrosis, and alpha 1-antitrypsin deficiency). These patients, termed patients with "bronchiolitis," underwent pulmonary function testing, bronchoscopy with bronchoalveolar lavage (BAL), and open lung biopsy. Although lung biopsy findings varied somewhat among the patients, each biopsy contained a prominent component of bronchiolitis. Pulmonary function testing and BAL were also repeated after 3 months of treatment with oral prednisone (1 mg/kg/day). Initial BAL neutrophil percentages were significantly higher in the bronchiolitis group (54 +/- 10%) than in smokers with chronic bronchitis (3.9 +/- 1.0%) or in normal nonsmoking volunteers (0.8 +/- 0.5%) (p less than 0.01, both comparisons). Eleven of 15 patients with bronchiolitis had significant improvement (greater than or equal to 15% increase in FEV1) in their lung function after prednisone treatment. Furthermore, this "responder" subgroup had a significant reduction in BAL neutrophil percentages after treatment with prednisone (46 +/- 15% to 6 +/- 3%, p less than 0.05). Finally, the neutrophil products collagenase and myeloperoxidase were detected in the BAL fluid of patients with bronchiolitis. These findings suggest a central role for the neutrophil in the pathogenesis of bronchiolitis and emphasize the utility of BAL in the identification of these patients.

摘要

在过去4年中,我们确定了16例成年患者,他们患有严重呼吸系统疾病的快速发作(通常本质上为阻塞性),在临床上与更常见的慢性阻塞性疾病(如慢性支气管炎、肺气肿、哮喘、支气管扩张、囊性纤维化和α1-抗胰蛋白酶缺乏症)不同。这些被称为“细支气管炎”患者的患者接受了肺功能测试、支气管镜检查及支气管肺泡灌洗(BAL)和开胸肺活检。尽管患者的肺活检结果有所不同,但每次活检均包含细支气管炎的显著成分。在口服泼尼松(1mg/kg/天)治疗3个月后,也重复进行了肺功能测试和BAL。细支气管炎组的初始BAL中性粒细胞百分比(54±10%)显著高于慢性支气管炎吸烟者(3.9±1.0%)或正常非吸烟志愿者(0.8±0.5%)(两组比较,p均<0.01)。15例细支气管炎患者中有11例在泼尼松治疗后肺功能有显著改善(FEV1增加≥15%)。此外,这个“有反应者”亚组在接受泼尼松治疗后BAL中性粒细胞百分比显著降低(从46±15%降至6±3%,p<0.05)。最后,在细支气管炎患者的BAL液中检测到中性粒细胞产物胶原酶和髓过氧化物酶。这些发现表明中性粒细胞在细支气管炎发病机制中起核心作用,并强调了BAL在识别这些患者中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验